YB9-31047-03800
2 vaccinations
7 coded responses
20 check-ins
7 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 704 / LA
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-17
- 2020-12-19
- 2020-12-20
- 2020-12-22
-
2020-12-23
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: Mild allergic rhinitis, no other symptoms, similar to other patients in our locale who are COVID negative. I have history of allergic rhinitis and have been off allergy medsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-24
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Survey response — days 1–6 daily, dose 2MedDRA: Night sweats — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to workFree text: Light night sweats last nightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-08
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Night sweats, Self-medication — Feeling: Fair · FeverFree text: After reported to you yesterday- at 6pm slight chill w temp100.2. Tylenol 1000 mg. Slight overnight sweat. A febrile by 3 am todayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
-
2021-01-14
Survey response — day 7, dose 2MedDRA: Adverse reaction, Self-medication — Feeling: Good · HeadacheFree text: 1/10 Rt frontal relieved w AcetaminophenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — day 14, dose 2MedDRA: Nightmare — Feeling: GoodFree text: Had increase nightmaresMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
- 2021-02-04
-
2021-02-11
Survey response — day 35, dose 2MedDRA: Radiculopathy — Feeling: GoodFree text: Left L4 - L5 radiculopathy (9/10)x5 days , now improving. No HZ lesions. Had previous ShingrixMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
-
2021-04-08
Survey response — 3 months, dose 2MedDRA: Herpes zoster, Radiculopathy — Feeling: GoodFree text: What I reported as left radiculopathy a few weeks after the second injection actually was probably Zoster. Never had skin lesions. Still have radiculopathy 1-4/10. No LS spine symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-08
- 2022-01-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-08 | priority 2/3 |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Mild allergic rhinitis, no other symptoms, similar to other patients in our locale who are COVID negative. I have history of allergic rhinitis and have been off allergy meds
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Light night sweats last night
Systemic reaction (other): After reported to you yesterday- at 6pm slight chill w temp100.2. Tylenol 1000 mg. Slight overnight sweat. A febrile by 3 am today
Release 2 — day 7, dose 2
Systemic reaction (other): 1/10 Rt frontal relieved w Acetaminophen
Release 2 — day 14, dose 2
Symptoms: Had increase nightmares
Release 4 — day 35, dose 2
Symptoms: Left L4 - L5 radiculopathy (9/10)x5 days , now improving. No HZ lesions. Had previous Shingrix
Release 7 — 3 months, dose 2
Symptoms: What I reported as left radiculopathy a few weeks after the second injection actually was probably Zoster. Never had skin lesions. Still have radiculopathy 1-4/10. No LS spine symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Herpes zoster | ✓ | ✓ | ✓ |
| SD | Nightmare | ✓ | ✓ | ✓ |
| SD | Radiculopathy | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Body temperature increased | ○ | ○ | ○ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rhinitis allergic | ○ | ○ | ○ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release